Literature DB >> 24857581

Hyperaldosteronism: diagnosis, lateralization, and treatment.

Adrian M Harvey1.   

Abstract

Primary hyperaldosteronism is an important and commonly unrecognized secondary cause of hypertension. This article provides an overview of the current literature with respect to screening, diagnosis, and lateralization. Selection and outcomes of medical and surgical treatment are discussed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenal venous sampling; Aldosterone; Aldosterone-to-renin ratio; Laparoscopic adrenalectomy; Primary hyperaldosteronism; Secondary hypertension

Mesh:

Substances:

Year:  2014        PMID: 24857581     DOI: 10.1016/j.suc.2014.02.007

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  NP-59 test for preoperative localization of primary hyperaldosteronism.

Authors:  Marcello Di Martino; Iñigo García Sanz; Jose Luis Muñoz de Nova; Cristina Marín Campos; Miguel Martínez Martín; Luis Domínguez Gadea
Journal:  Langenbecks Arch Surg       Date:  2017-02-21       Impact factor: 3.445

2.  Successful Adrenal Vein Sampling Using Dexamethasone Premedication in Patients With Iodine Contrast Media Allergy.

Authors:  Nada Younes; Eric Therasse; Isabelle Bourdeau; André Lacroix
Journal:  J Endocr Soc       Date:  2022-06-16

3.  Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?

Authors:  Damian G Romero; Licy L Yanes Cardozo
Journal:  Int J Endocrinol Metab Disord       Date:  2016-07-11

Review 4.  A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis.

Authors:  Sandra Korol; Fannie Mottet; Sylvie Perreault; William L Baker; Michel White; Simon de Denus
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

5.  Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan.

Authors:  Ming-Hsien Wu; Feng-Hsuan Liu; Kun-Ju Lin; Jui-Hung Sun; Szu-Tah Chen
Journal:  Nucl Med Commun       Date:  2019-06       Impact factor: 1.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.